Rayence Co., Ltd. (KOSDAQ:228850)
South Korea · Delayed Price · Currency is KRW 5,830.00
+630.00 (12.12%)
At close: Feb 27, 2026
Rayence Revenue
In the year 2025, Rayence had annual revenue of 114.72B KRW, down -8.63%. Rayence had revenue of 29.13B in the quarter ending December 31, 2025, with 12.91% growth.
Revenue
114.72B
Revenue Growth
-8.63%
P/S Ratio
0.80
Revenue / Employee
512.16M
Employees
224
Market Cap
91.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 114.72B | -10.84B | -8.63% |
| Dec 31, 2024 | 125.56B | -17.42B | -12.18% |
| Dec 31, 2023 | 142.99B | -4.17B | -2.84% |
| Dec 31, 2022 | 147.16B | 12.59B | 9.36% |
| Dec 31, 2021 | 134.57B | 33.04B | 32.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| YES24 Co.,Ltd | 651.79B |
| Woowon Development | 379.63B |
| Ahn-Gook Pharmaceutical | 300.96B |
| YOUNGHWA TECH | 107.79B |
| Mr. Blue | 69.96B |
| HUMAN TECHNOLOGY | 49.31B |
| Topco Media | 40.38B |
| DIGITAL CHOSUN | 38.44B |